Cargando…

B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Gay, F, Berdeja, JG, De Stefano, V, Hari, P, Hooper, B, Haltner, A, Kumar, S, Martin, T, Mateos, M-V, Moreau, P, Rosta, E, Samjoo, IA, Usmani, SZ, Weisel, K, Jackson, CC, Olyslager, Y, Schecter, JM, Vogel, M, Garrett, A, Lee, S, Nesheiwat, T, Pacaud, L, Zhou, C, Valluri, S, Costa, LJ, Lin, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009793/
http://dx.doi.org/10.1097/01.HS9.0000829560.21894.ee
_version_ 1784687340814336000
author Gay, F
Berdeja, JG
De Stefano, V
Hari, P
Hooper, B
Haltner, A
Kumar, S
Martin, T
Mateos, M-V
Moreau, P
Rosta, E
Samjoo, IA
Usmani, SZ
Weisel, K
Jackson, CC
Olyslager, Y
Schecter, JM
Vogel, M
Garrett, A
Lee, S
Nesheiwat, T
Pacaud, L
Zhou, C
Valluri, S
Costa, LJ
Lin, Y
author_facet Gay, F
Berdeja, JG
De Stefano, V
Hari, P
Hooper, B
Haltner, A
Kumar, S
Martin, T
Mateos, M-V
Moreau, P
Rosta, E
Samjoo, IA
Usmani, SZ
Weisel, K
Jackson, CC
Olyslager, Y
Schecter, JM
Vogel, M
Garrett, A
Lee, S
Nesheiwat, T
Pacaud, L
Zhou, C
Valluri, S
Costa, LJ
Lin, Y
author_sort Gay, F
collection PubMed
description
format Online
Article
Text
id pubmed-9009793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90097932022-04-18 B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA Gay, F Berdeja, JG De Stefano, V Hari, P Hooper, B Haltner, A Kumar, S Martin, T Mateos, M-V Moreau, P Rosta, E Samjoo, IA Usmani, SZ Weisel, K Jackson, CC Olyslager, Y Schecter, JM Vogel, M Garrett, A Lee, S Nesheiwat, T Pacaud, L Zhou, C Valluri, S Costa, LJ Lin, Y Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9009793/ http://dx.doi.org/10.1097/01.HS9.0000829560.21894.ee Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Best Abstracts - Oral Presentations
Gay, F
Berdeja, JG
De Stefano, V
Hari, P
Hooper, B
Haltner, A
Kumar, S
Martin, T
Mateos, M-V
Moreau, P
Rosta, E
Samjoo, IA
Usmani, SZ
Weisel, K
Jackson, CC
Olyslager, Y
Schecter, JM
Vogel, M
Garrett, A
Lee, S
Nesheiwat, T
Pacaud, L
Zhou, C
Valluri, S
Costa, LJ
Lin, Y
B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
title B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
title_full B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
title_fullStr B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
title_short B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
title_sort b05: results from a meta-analysis of ciltacabtagene autoleucel compared to physician’s choice of treatment in patients with relapsed or refractory multiple myeloma
topic Best Abstracts - Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009793/
http://dx.doi.org/10.1097/01.HS9.0000829560.21894.ee
work_keys_str_mv AT gayf b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT berdejajg b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT destefanov b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT harip b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT hooperb b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT haltnera b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT kumars b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT martint b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT mateosmv b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT moreaup b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT rostae b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT samjooia b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT usmanisz b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT weiselk b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT jacksoncc b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT olyslagery b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT schecterjm b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT vogelm b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT garretta b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT lees b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT nesheiwatt b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT pacaudl b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT zhouc b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT valluris b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT costalj b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma
AT liny b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma